Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients

NCT01469884

PHASE4INTERVENTIONAL

Irmandade Santa Casa de Misericórdia de Porto Alegre

30 participants

Started 2011-11 · Completed 2015-04

Status: Completed (as of 12-23-2025)

Conditions

Renal AllograftHepatitis C

Interventions

DRUG: Everolimus DRUG: Cyclosporine DRUG: Tacrolimus

Linked Papers (from SciSciNet-V2)

Total Papers6

Background

0

Result

0

Derived

0

Unknown

6

View on ClinicalTrials.gov

Total Citations Per Year

Brief Summary

Compare the viral load of hepatitis c virus in patients converted to certican versus patients who are maintained on calcineurin inhibitor.

Sort by:

Background Papers0

No background papers linked

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers6

HEPATITIS C ANTIBODY STATUS AND OUTCOMES IN RENAL TRANSPLANT RECIPIENTS

First Report on a Series of HIV Patients Undergoing Rapamycin Monotherapy After Liver Transplantation

Sirolimus has a potential to influent viral recurrence in HCV positive liver transplant candidates

Different Impacts of Hepatitis B Virus and Hepatitis C Virus on the Outcome of Kidney Transplantation

Switching to Sirolimus in Renal Transplant Recipients With Hepatitis C Virus: A Safe Option

Immune status in renal transplant recipients with hepatitis C virus infection